Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FENAUX P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 267 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fenaux, P; Chomienne, C; Degos, L
      Treatment of acute promyelocytic leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    2. Rose, C; Cambier, N; Mahieu, M; Ernst, O; Fenaux, P
      Iron overload and myelodysplastic syndromes.

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    3. Deruelle, R; Catteau, B; Segard, M; De Lassalle, EM; Fenaux, P; Piette, F
      Cutaneous granulocytic sarcoma arising at the site of radiotherapy for breast carcinoma

      EUROPEAN JOURNAL OF DERMATOLOGY
    4. Fenaux, P
      Chromosome and molecular abnormalities in myelodysplastic syndromes

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    5. Fenaux, P; Bourhis, JH; Ribrag, V
      Burkitt's acute lymphocytic leukemia (L(3)ALL) in adults

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    6. Soenen, V; Lepelley, P; Gyan, E; Preudhomme, C; Lai, JL; Bauters, F; Fenaux, P; Quesnel, B
      Prognostic significance of p16(INK4a) immunocytochemistry in adult ALL with standard risk karyotype

      LEUKEMIA
    7. Ribrag, V; Hajj, ME; Janot, F; Girinsky, T; Domenge, C; Schwaab, G; Fenaux, P; Bosq, J
      Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx

      LEUKEMIA
    8. Bourgeois, E; Caulier, MT; Rose, C; Dupriez, B; Bauters, F; Fenaux, P
      Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases

      LEUKEMIA
    9. Greenberg, P; Anderson, J; Estey, E; Fenaux, P; Hamblin, T; Hellstrom-Lindberg, E; List, A; Ohyashiki, K; Sanz, G; Zanz, M
      Classifying chronic myelomonocytic leukemia - In Reply

      JOURNAL OF CLINICAL ONCOLOGY
    10. Vantelon, JM; Munck, JN; Bourhis, JH; Pico, JL; Fadel, C; Ulusakarya, A; Carde, P; Fenaux, P; Ribrag, V
      Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy

      BONE MARROW TRANSPLANTATION
    11. Fenaux, P; Chomienne, C; Degos, L
      All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia

      SEMINARS IN HEMATOLOGY
    12. Ribrag, V; Bibeau, F; El Weshi, A; Frayfer, J; Fadel, C; Cebotaru, C; Laribi, K; Fenaux, P
      Primary breast lymphoma: a report of 20 cases

      BRITISH JOURNAL OF HAEMATOLOGY
    13. Nisse, C; Haguenoer, JM; Grandbastien, B; Preudhomme, C; Fontaine, B; Brillet, JM; Lejeune, R; Fenaux, P
      Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France

      BRITISH JOURNAL OF HAEMATOLOGY
    14. Cassinat, B; Chevret, S; Zassadowski, F; Balitrand, N; Guillemot, I; Menot, ML; Degos, L; Fenaux, P; Chomienne, C
      In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome

      BLOOD
    15. Guillerm, G; Gyan, E; Wolowiec, D; Facon, T; Avet-Loiseau, H; Kuliczkowski, K; Bauters, F; Fenaux, P; Quesnel, B
      p16(INK4a) and p15(INK4b) gene methylations in plasma cells from monoclonal gammopathy of undetermined significance

      BLOOD
    16. Cassinat, B; Chevret, S; Balitrand, N; Zassowski, F; Barbey, C; Degos, L; Fenaux, P; Chomienne, C
      APL biology

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    17. Vereecque, R; Buffenoir, G; Preudhomme, C; Hetuin, D; Bauters, F; Fenaux, P; Quesnel, B
      Gene transfer of GM-CSF, CD80 and CD154 cDNA enhances survival in a murinemodel of acute leukemia with persistence of a minimal residual disease

      GENE THERAPY
    18. Preudhomme, C; Roumier, C; Hildebrand, MP; Dallery-Prudhomme, E; Lantoine, D; Lai, JL; Daudignon, A; Adenis, C; Bauters, F; Fenaux, P; Kerckaert, JP; Galiegue-Zouitina, S
      Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-bindingprotein, in non-Hodgkin's lymphoma and multiple myeloma

      ONCOGENE
    19. Hofmann, WK; Kell, WJ; Fenaux, P; Castaigne, S; Ganser, A; Chomienne, C; Burnett, R; Kowal, C; Hoelzer, D; Burnett, AK
      Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study

      LEUKEMIA
    20. Fenaux, P; Chevret, S; Guerci, A; Fegueux, N; Dombret, H; Thomas, X; Sanz, M; Link, H; Maloisel, F; Gardin, C; Bordessoule, D; Stoppa, AM; Sadoun, A; Muus, P; Wandt, H; Mineur, P; Whittaker, JA; Fey, M; Daniel, MT; Castaigne, S; Degos, L
      Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

      LEUKEMIA
    21. Thomas, X; Dombret, H; Cordonnier, C; Pigneux, A; Gardin, C; Guerci, A; Vekhoff, A; Sadoun, A; Stamatoullas, A; Fegueux, N; Maloisel, F; Cahn, JY; Reman, O; Gratecos, N; Berthou, C; Huguet, F; Kotoucek, P; Travade, P; Buzyn, A; de Revel, T; Vilque, JP; Naccache, P; Chomienne, C; Degos, L; Fenaux, P
      Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation

      LEUKEMIA
    22. Cassinat, B; Zassadowski, F; Balitrand, N; Barbey, C; Rain, JD; Fenaux, P; Degos, L; Vidaud, M; Chomienne, C
      Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR

      LEUKEMIA
    23. Solary, E; Mannone, L; Moreau, D; Caillot, D; Casasnovas, RO; Guy, H; Grandjean, M; Wolf, JE; Andre, F; Fenaux, P; Canal, P; Chauffert, B; Wotawa, A; Bayssas, M; Gennes, P
      Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes

      LEUKEMIA
    24. Morschhauser, F; Cayuela, JM; Martini, S; Baruchel, A; Rousselot, P; Socie, G; Berthou, P; Jouet, JP; Straetmans, N; Sigaux, F; Fenaux, P; Preudhomme, C
      Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: A multicenter study of 51 patients

      JOURNAL OF CLINICAL ONCOLOGY
    25. Greenberg, P; Anderson, J; de Witte, T; Estey, E; Fenaux, P; Gupta, P; Hamblin, T; Hellstrom-Lindberg, E; List, A; Mufti, G; Neuwirtova, R; Ohyashiki, K; Oscier, D; Sanz, G; Sanz, M; Willman, C
      Problematic WHO reclassification of myelodysplastic syndromes

      JOURNAL OF CLINICAL ONCOLOGY
    26. Cambier, N; Soenen-Cornu, V; Lai, JL; Cosson, A; Fenaux, P; Preudhomme, C
      Investigation of minimal residual disease in adult Ph1 positive acute lymphoblastic leukemia by a combination of cell sorting and fluorescence in situ hybridization: a preliminary study on 6 cases

      HAEMATOLOGICA
    27. Vantelon, JM; Koscielny, S; Brault, P; Bourhis, JH; Ribrag, V; Pico, J; Fenaux, P; Munck, JN
      Scoring system for the prediction of successful peripheral blood stem cell(PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinicalpractice

      BONE MARROW TRANSPLANTATION
    28. de Botton, S; Chevret, S; Sanz, M; Dombret, H; Thomas, X; Guerci, A; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Geiser, K; Hess, U; Maloisel, F; Castaigne, S; Preudhomme, C; Chomienne, C; Degos, L; Fenaux, P
      Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial

      BRITISH JOURNAL OF HAEMATOLOGY
    29. Poulain, S; Lepelley, P; Preudhomme, C; Cambier, N; Cornillon, J; Wattel, E; Cosson, A; Fenaux, P
      Expression of the multidrug resistance-associated protein in myelodysplastic syndromes

      BRITISH JOURNAL OF HAEMATOLOGY
    30. Vereecque, R; Buffenoir, G; Gonzalez, R; Cambier, N; Hetuin, D; Bauters, F; Fenaux, P; Quesnel, B
      gamma-Ray irradiation induces B7.1 expression in myeloid leukaemic cells

      BRITISH JOURNAL OF HAEMATOLOGY
    31. Preudhomme, C; Warot-Loze, D; Roumier, C; Grardel-Duflos, N; Garand, R; Lai, JL; Dastugue, N; Macintyre, E; Denis, C; Bauters, F; Kerckaert, JP; Cosson, A; Fenaux, P
      High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21

      BLOOD
    32. Preudhomme, C; Warot-Loze, D; Roumier, C; Grardel-Duflos, N; Garand, R; Lai, JL; Dastugue, N; Macintyre, E; Denis, C; Bauters, F; Kerckaert, JP; Cosson, A; Fenaux, P
      High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21

      BLOOD
    33. Agape, P; Copin, MC; Cavrois, M; Panelatti, G; Plumelle, Y; Ossondo-Landeau, M; Quist, D; Grossat, N; Gosselin, B; Fenaux, P; Wattel, E
      Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies)

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    34. Gonzalez, R; Vereecque, R; Wickham, TJ; Facon, T; Hetuin, D; Kovesdi, I; Bauters, F; Fenaux, P; Quesnel, B
      Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells

      HUMAN GENE THERAPY
    35. Quesnel, B; Fenaux, P
      p15(INK4b) gene methylation and myelodysplastic syndromes

      LEUKEMIA & LYMPHOMA
    36. Gonzalez, R; Vereecque, R; Wickham, TJ; Vanrumbeke, M; Kovesdi, I; Bauters, F; Fenaux, P; Quesnel, B
      Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein

      GENE THERAPY
    37. Thomas, X; Fenaux, P; Dombret, H; Delair, S; Dreyfus, F; Tilly, H; Vekhoff, A; Cony-Makhoul, P; Leblond, V; Troussard, X; Cordonnier, C; de Revel, T; Simon, M; Nicolini, F; Stoppa, AM; Janvier, M; Bordessoule, D; Rousselot, P; Ffrench, M; Marie, JP; Archimbaud, E
      Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)

      LEUKEMIA
    38. Preudhomme, C; Revillion, F; Merlat, A; Hornez, L; Roumier, C; Duflos-Grardel, N; Jouet, JP; Cosson, A; Peyrat, JP; Fenaux, P
      Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a'real time' quantitative RT-PCR assay

      LEUKEMIA
    39. Preudhomme, C; Chams-Eddine, L; Roumier, C; Duflos-Grardel, N; Denis, C; Cosson, A; Fenaux, P
      Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay

      LEUKEMIA
    40. Wattel, E; Solary, E; Leleu, X; Dreyfus, F; Brion, A; Jouet, JP; Hoang-Ngoc, L; Maloisel, F; Guerci, A; Rochant, H; Gratecos, N; Casassus, P; Janvier, M; Brice, P; Lepelley, P; Fenaux, P
      A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes

      LEUKEMIA
    41. Merlat, A; Lai, JL; Sterkers, Y; Demory, JL; Bauters, F; Preudhomme, C; Fenaux, P
      Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases

      LEUKEMIA
    42. Plantier-Colcher, I; Dupriez, B; Simon, M; Detourmignies, L; Jouet, JP; Fenaux, P; Bauters, F; Morel, P
      The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases

      LEUKEMIA
    43. Bouabdallah, R; Lefrere, F; Rose, C; Chaibi, P; Harousseau, JL; Vernant, JP; Castaigne, S; Bauduer, F; Zini, JM; Coso, D; Varet, B; Robert, J; Fenaux, P
      A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients

      LEUKEMIA
    44. Roumier, C; Daudignon, A; Soenen, V; Dupriez, B; Wetterwald, M; Lai, JL; Cosson, A; Fenaux, P; Preudhomme, C
      p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?

      HAEMATOLOGICA
    45. Van Camp, B; Fenaux, P
      Multiple Myeloma - A model of nature - Introduction

      PATHOLOGIE BIOLOGIE
    46. Ulusakarya, A; Vantelon, JM; Munck, JN; Fenaux, P; Rerat, K
      Thiamine deficiency in a patient receiving chemotherapy for acute myeloblastic leukemia

      AMERICAN JOURNAL OF HEMATOLOGY
    47. Vereecque, R; Buffenoir, G; Gonzalez, R; Preudhomme, C; Fenaux, P; Quesnel, B
      A new murine aggressive leukemic model

      LEUKEMIA RESEARCH
    48. Beris, P; Samii, K; Darbellay, R; Zoumbos, N; Tsoplou, P; Kourakli, A; Preud'homme, C; Fenaux, P
      Iron overload in patients with sideroblastic anaemia is not related to thepresence of the haemochromatosis Cys282Tyr and His63Asp mutations

      BRITISH JOURNAL OF HAEMATOLOGY
    49. Fenaux, P; Chastang, C; Chevret, S; Sanz, M; Dombret, H; Archimbaud, E; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Maloisel, F; Castaigne, S; Preudhomme, C; Degos, L
      A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia

      BLOOD
    50. Archimbaud, E; Ottmann, OG; Yin, JAL; Lechner, K; Dombret, H; Sanz, MA; Heil, G; Fenaux, P; Brugger, W; Barge, A; O'Brien-Ewen, C; Matcham, J; Hoelzer, D
      A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as anadjunct to chemotherapy for adults with de novo acute myeloid leukemia

      BLOOD
    51. Chevret, S; Degos, L; Fenaux, P
      Rate requested from the subgroups studied in the APL93 trial - Response

      BLOOD
    52. Fenaux, P
      Myelodysplastic syndromes

      TEXTBOOK OF MALIGNANT HAEMATOLOGY
    53. LEPELLEY P; GRARDEL N; ERNY O; IARU T; OBEIN V; COSSON A; FENAUX P
      FAS APO-1 (CD95) EXPRESSION IN MYELODYSPLASTIC SYNDROMES/

      Leukemia & lymphoma
    54. LEPELLEY P; POULAIN S; GRARDEL N; PREUDHOMME C; COSSON A; FENAUX P
      EXPRESSION OF LUNG RESISTANCE PROTEIN AND CORRELATION WITH OTHER DRUG-RESISTANCE PROTEINS AND OUTCOME IN MYELODYSPLASTIC SYNDROMES

      Leukemia & lymphoma
    55. SOENEN V; PREUDHOMME C; ROUMIER C; LAI JL; LEPELLEY P; FACON T; PAGNIEZ D; FENAUX P
      MYELODYSPLASIA DURING THE COURSE OF MYELOMA - RESTRICTION OF 17P DELETION AND P53 OVEREXPRESSION TO MYELOID CELLS

      Leukemia
    56. FOUILLARD L; LAPORTE JP; LABOPIN M; LESAGE S; ISNARD F; DOUAY L; LOPEZ M; AOUDJHANE M; ZUNIC P; CHERON N; STACHOWIAK J; LEMONNIER MP; ANDREU G; BELKACEMI Y; NOELWALTER MP; MOREL P; FENAUX P; JOUET JP; BAUTERS F; NAJMAN A; GORIN NC
      AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMAS - THEROLE OF GRAFT PURGING AND RADIOTHERAPY POSTTRANSPLANTATION - RESULTS OF A RETROSPECTIVE ANALYSIS ON 120 PATIENTS AUTOGRAFTED IN A SINGLE INSTITUTION

      Journal of clinical oncology
    57. VALLESPI T; IMBERT M; MECUCCI C; PREUDHOMME C; FENAUX P
      DIAGNOSIS, CLASSIFICATION, AND CYTOGENETICS OF MYELODYSPLASTIC SYNDROMES

      Haematologica
    58. LAI JL; DAUDIGNON A; KERCKAERT JP; GALIEGUEZOUITINA S; DETOURMIGNIES L; MOREL P; BAUTERS F; FENAUX P
      TRANSLOCATION (3-13)(Q27-Q14) - A NONRANDOM AND PROBABLY SECONDARY STRUCTURAL-CHANGE IN NON-HODGKIN LYMPHOMAS

      Cancer genetics and cytogenetics
    59. Fenaux, P
      Introduction to the special issue of Leukemia Research

      LEUKEMIA RESEARCH
    60. FENAUX P; DEBOTTON S
      RETINOIC ACID SYNDROME - RECOGNITION, PREVENTION AND MANAGEMENT

      Drug safety
    61. VANUFFELEN M; JUCKER P; FENAUX P
      RADIATION-RESISTANCE OF FIBEROPTIC COMPONENTS AND PREDICTIVE MODELS FOR OPTICAL-FIBER SYSTEMS IN NUCLEAR ENVIRONMENTS

      IEEE transactions on nuclear science
    62. WATTEL E; SOLARY E; HECQUET B; CAILLOT D; IFRAH N; BRION A; MAHE B; MILPIED N; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; BUZYN A; HOANGNGOC L; STOPPA AM; GRATECOS N; SADOUN A; STAMATOULAS A; TILLY H; BRICE P; MALOISEL F; LIOURE B; DESABLENS B; PIGNON B; ABGRALL JP; LEPORRIER M; DUPRIEZ B; GUYOTAT D; LEPELLEY P; FENAUX P
      QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY

      British Journal of Haematology
    63. CASSINAT B; CHEVRET S; BALITRAND N; ZASSADOWSKI F; BARBEY C; RAIN JD; DEGOS L; FENAUX P; CHOMIENNE C
      ACUTE PROMYELOCYTIC LEUKEMIA - PROGNOSTIC-SIGNIFICANCE OF PML-RAR-ALPHA TYPING AND IN-VITRO ATRA DIFFERENTIATING EFFICIENCY ON LEUKEMIC BLASTS

      British Journal of Haematology
    64. MORSCHHAUSER F; CAYUELA JM; MARTINI S; BARUCHEL A; ROUSSELOT P; SOCIE G; JOUET JP; STRAETMANS N; MARTIAT P; FENAUX P; PREUDHOMME C
      EVALUATION OF MINIMAL RESIDUAL DISEASE USING RT-PCR IN 37 T(8,21) AMLPATIENTS

      British Journal of Haematology
    65. MORSCHHAUSER F; FOURNIER M; FENAUX P; CHOMIENNE C; PREUDHOMME C
      DIAGNOSIS AND FOLLOW-UP OF MINIMAL RESIDUAL DISEASE (MRD) IN APL USING FISH ANALYSIS

      British Journal of Haematology
    66. SOENEN V; LEPELLEY P; LAI JL; VANRUMBEKE M; PREUDHOMME C; BAUTERS F; FENAUX P; QUESNEL B
      IMMUNOCYTOCHEMISTRY - A SUITABLE METHOD FOR DETECTION OF P16 HOMOZYGOUS DELETION IN ACUTE LYMPHOBLASTIC-LEUKEMIA

      British Journal of Haematology
    67. THOMAS X; CORDONNIER C; DOMBRET H; FEGUEUX N; MALOISEL F; VEKHOFF A; REMAN O; VILQUE JP; GRATECOS N; DEREVEL T; COASIN T; BUZYN A; CAHN JY; GUERCI A; CHOMIENNE C; ARCHIMBAUD E; DEGOS L; FENAUX P
      ALL-TRANS-RETINOIC ACID (ATRA) FOLLOWED BY TIMED SEQUENTIAL CHEMOTHERAPY (EMA) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (APBSCT) IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA (APL)

      British Journal of Haematology
    68. ARCHIMBAUD E; FENAUX P; DOMBRET H; DREYFUS F; TILLY H; CONYMAKHOUL P; LEBLOND V; TROUSSARD X; DELAIR S; FFRENCH M; MARIE JP
      GM-CSF TO INCREASE EFFICACY OF SEQUENTIAL CHEMOTHERAPY IN PREVIOUSLY TREATED ACUTE MYELOID-LEUKEMIA (AML) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL (EMA91)

      British Journal of Haematology
    69. CASTAIGNE S; ARCHIMBAUD A; BORDESSOULE D; TILLY H; DOMBRET H; DEREVEL T; SIMON M; RENOUX M; JANVIER M; GROSBOIS M; DUPRIEZ B; ZINI JM; TERTIAN G; BAY O; FENAUX P; DEGOS L; CHASTANG C
      INTENSIFIED INDUCTION CHEMOTHERAPY INCREASE REMISSION DURATION IN DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) PATIENTS AGED LESS-THAN 50 YEARS - LONG-TERM RESULTS OF LAM-90 TRIAL

      British Journal of Haematology
    70. CAMBIER N; COSSEMENT C; COSSON A; LAI JL; FENAUX P; PREUDHOMME C
      INVESTIGATION OF MINIMAL RESIDUAL DISEASE (MRD) IN PH-1 POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) BY A COMBINATION OF CELL SORTING (CD34-SITU HYBRIDIZATION (FISH)( CELLS) AND FLUORESCENCE IN)

      British Journal of Haematology
    71. WATTEL E; SOLARY E; HECQUET B; CAILLOT D; IFRAH N; BRION A; MILPIED N; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; VEIL A; HOANGNGOC L; STOPPA AM; GRATECOS N; SADOUN A; TILLY H; BRICE B; GUYOTAT D; LEPELLEY P; FENAUX P
      QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY

      British Journal of Haematology
    72. PREUDHOMME C; HORNEZ L; MERLAT A; PRUVOT D; LAINE AL; COSSON A; PEYRAT JP; FENAUX P
      DETECTION OF BCR-ABL TRANSCRIPTS IN CHRONIC MYELOID-LEUKEMIA (CML) USING A NOVEL REAL-TIME QUANTITATIVE RT-PCR ASSAY (TAQ MAN CHEMISTRY)

      British Journal of Haematology
    73. SMETSERS T; CAYUELA JM; MORSCHHAUSER F; MARTINI S; MENSINK EJBM; FENAUX P; PREUDHOMME C
      EVALUATION OF MINIMAL RESIDUAL DISEASE USING REAL-TIME QUANTITATIVE RT-PCR (TAQ MAN CHEMISTRY) IN T(8,21) AML PATIENTS

      British Journal of Haematology
    74. WATTEL E; LELEU X; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; JOUET JP; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGUEUX N; GUYOTAT D; BRICE P; LEPELLEY P; FENAUX P
      AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)

      British Journal of Haematology
    75. KELL WJ; HOFMANN WK; HOELZER D; CHOMIENNE C; GANSER A; FENAUX P; CASTAIGNE S; BURNETT R; BURNETT AK
      9-CIS-RETINOIC ACID TREATMENT FOR MYELODYSPLASIA

      British Journal of Haematology
    76. MICHALLET AS; LAI JL; BAUTERS F; FENAUX P; QUESNEL B
      A NEW CASE OF THERAPY-RELATED ACUTE MYELOID-LEUKEMIA WITH T(8-16)(P11-P13)

      British Journal of Haematology
    77. PREUDHOMME C; VANRUMBEKE M; DETOURMIGNIES L; FACON T; LEPELLEY P; SOUSSI T; FENAUX P
      VERY-LOW INCIDENCE OF P53 ANTIBODIES IN ADULT NON-HODGKINS-LYMPHOMA AND MULTIPLE-MYELOMA

      British Journal of Haematology
    78. DEBOTTON S; DOMBRET H; SANZ M; SANMIGUEL J; CAILLOT D; ZITTOUN R; GARDEMBAS M; STAMATOULAS A; CONDE E; GUERCI A; GARDIN C; GEISER K; MAKHOUL DC; REMAN O; DELASERNA J; LEFRERE F; CHOMIENNE C; CHASTANG C; DEGOS L; FENAUX P
      INCIDENCE, CLINICAL-FEATURES, AND OUTCOME OF ALL-TRANS-RETINOIC ACID SYNDROME IN 413 CASES OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    79. FENAUX P; PREUDHOMME C; LAI JL; STERKERS Y
      IS HYDROXYUREA LEUKEMOGENIC IN ESSENTIAL THROMBOCYTHEMIA - RESPONSE

      Blood
    80. SOENEN V; PREUDHOMME C; ROUMIER C; DAUDIGNON A; LAI JL; FENAUX P
      17P DELETION IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME -ANALYSIS OF BREAKPOINTS AND DELETED SEGMENTS BY FLUORESCENCE IN-SITU

      Blood
    81. STERKERS Y; PREUDHOMME C; LAI JL; DEMORY JL; CAULIER MT; WATTEL E; BORDESSOULE D; BAUTERS F; FENAUX P
      ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROMES FOLLOWING ESSENTIAL THROMBOCYTHEMIA TREATED WITH HYDROXYUREA - HIGH PROPORTION OF CASES WITH 17P DELETION

      Blood
    82. CAMBIER N; BARUCHEL A; SCHLAGETER MH; MENOT ML; WATTEL E; FENAUX P; CHOMIENNE C
      CHRONIC MYELOMONOCYTIC LEUKEMIA - FROM BIOLOGY TO THERAPY

      HEMATOLOGY AND CELL THERAPY
    83. PADUA RA; WARREN N; GRIMSHAW D; SMITH M; LEWIS C; WHITTAKER J; LAIDLER P; WRIGHT P; DOUGLASJONES A; FENAUX P; SHARMA A; HORGAN K; WEST R
      THE CYSTIC-FIBROSIS DELTA-F508 GENE-MUTATIONS AND CANCER

      Human mutation
    84. HOELZER D; HOFMANN WK; OTTMANN OG; DOMBRET H; HERRMANN F; GANSER A; KANZ L; FENAUX P; YIN JAL; LECHNER K; SANZ MA; ARCHIMBAUD E
      EFFECT OF PEG-RHU MGDF IN THE INDUCTION TREATMENT OF ACUTE MYELOID-LEUKEMIA

      European journal of cancer
    85. VEREECQUE R; GONZALEZ R; BUFFENOIR G; HETUIN D; VANRUMBEKE M; FENAUX P; QUESNEL B
      VARIABLE EFFECT ON TUMORIGENICITY OF EXPRESSION OF B7.1 AND OR GM-CSFIN SYNGENEIC MYELOID LEUKEMIC MOUSE MODEL/

      Cancer gene therapy
    86. PREUDHOMME C; NISSE C; HEBBAR M; VANRUMBEKE M; BRIZARD A; LAI JL; FENAUX P
      GLUTATHIONE-S-TRANSFERASE THETA-1 GENE DEFECTS IN MYELODYSPLASTIC SYNDROMES AND THEIR CORRELATION WITH KARYOTYPE AND EXPOSURE TO POTENTIAL CARCINOGENS

      Leukemia
    87. PREUDHOMME C; HENIC N; CAZIN B; LAI JL; BERTHEAS MF; VANRUMBEKE M; LEMOINE F; JOUET JP; DECONNINCK E; NELKEN B; COSSON A; FENAUX P
      GOOD CORRELATION BETWEEN RT-PCR ANALYSIS AND RELAPSE IN PHILADELPHIA (PH1)-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)

      Leukemia
    88. HEBBAR M; KOZLOWSKI D; WATTEL E; MASTRINI S; DIEVART M; DUCLOS B; BONAZ B; DALMAGNE H; BELAICHE J; COLOMBEL JF; FENAUX P
      ASSOCIATION BETWEEN MYELODYSPLASTIC SYNDROMES AND INFLAMMATORY BOWEL DISEASES - REPORT OF 7 NEW CASES AND REVIEW OF THE LITERATURE

      Leukemia
    89. FENAUX P; CHOMIENNE C
      TREATMENT OF MALIGNANT HEMATOLOGY DISEASES WITH ALL TRANSRETINOIC ACID

      La Presse medicale
    90. FENAUX P
      TREATMENT STRATEGY FOR MYELODYSPLASTIC SY NDROMES

      Pathologie et biologie
    91. FENAUX P
      EDITORIAL - MYELODYSPLASTIC SYNDROMES

      Pathologie et biologie
    92. LAI JL; FENAUX P
      CYTOGENETIC OF MYELODYSPLASTIC SYNDROMES

      Pathologie et biologie
    93. FENAUX P; PREUDHOMME C
      MOLECULAR ABNORMALITIES AND CLONALITY IN MYELODYSPLASTIC SYNDROMES

      Pathologie et biologie
    94. PREUDHOMME C; FENAUX P
      P53 AND HEMATOLOGICAL MALIGNANCIES

      Pathologie et biologie
    95. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; IFRAH N; ABGRALL JP; GUYOTAT D; DUPRIEZ B; PENY AM; BRICE P; PIGNON B; LEPORRIER M; LEPELLEY P; FENAUX P
      INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS)

      Experimental hematology
    96. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; JOUET JP; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; GUYOTAT D; BRICE P; LEPELLEY P; FENAUX P
      AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)

      Experimental hematology
    97. FOUILLARD L; LAPORTE JP; LABOPIN M; LESAGE S; ISNARD F; DOUAY L; LOPEZ M; AOUDJHANE M; ZUNIC P; CHERON N; STACHOWIAK J; LEMONNIER MP; ANDREU G; BELKACEMI Y; NOELWALTER MP; MOREL P; FENAUX P; JOUET JP; BAUTERS F; NAJMAN A; GORIN NC
      CAN IN-VITRO PURGING AND POSTTRANSPLANT RADIOTHERAPY (PTRT) IMPROVE SURVIVAL IN PATIENTS (PTS) WITH NON-HODGKINS-LYMPHOMAS (NHL) FOLLOWING AUTOLOGOUS STEM-CELL

      Experimental hematology
    98. DEBOTTON S; WATTEL E; BAUTERS F; FENAUX P
      LONG-TERM SURVIVAL AFTER INTENSIVE CHEMOTHERAPY IN DE-NOVO MDS - LILLES EXPERIENCE

      Experimental hematology
    99. WATTEL E; DEBOTTON S; HEBBAR M; MERLAT A; BAUTERS F; FENAUX P
      INTENSIVE CHEMOTHERAPY IN DE-NOVO MDS - OUTCOME OF PATIENTS WHO ACHIEVED PARTIAL REMISSION (PR)

      Experimental hematology
    100. FENAUX P
      HEMATOPOIETIC GROWTH-FACTORS IN THE TREAT MENT OF HEMATOLOGICAL MALIGNANCIES

      La Revue de medecine interne


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 23:25:46